Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry. Scientific reports. 2021;11(1):11091.
28/02/2022
Prior-Español A, Sánchez-Piedra C, Campos J, Manero FJ, Pérez-García C, Bohórquez C, et al.
doi: 10.1038/s41598-021-90442-w.